CompletedPhase 4NCT02322879
Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing
Studying Paracetamol poisoning
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beth Israel Deaconess Medical Center
- Principal Investigator
- Steven Salhanick, MDBeth Israel Deaconess Medical Center
- Intervention
- First Treatment Period(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 20-40 years · All sexes
- Timeline
- 2013 – 2016
Study locations (1)
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Collaborators
Harvard University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02322879 on ClinicalTrials.govOther trials for Paracetamol poisoning
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06549062Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.University Hospital, Ghent
- RECRUITINGNCT04964310Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control StudyThe First Affiliated Hospital with Nanjing Medical University